Trial Profile
A non-interventional prospective post-authorisation study of epoetin theta in patients with chronic kidney disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Dec 2015
Price :
$35
*
At a glance
- Drugs Epoetin theta (Primary) ; Epoetin theta (Primary)
- Indications Anaemia
- Focus Adverse reactions
- 31 Dec 2015 New trial record
- 18 Dec 2015 Results published in the Clinical Therapeutics